Sentien’s mission is to harness the power of cell therapy with innovative drug delivery systems to treat a wide range of acute inflammatory diseases. Our lead product is designed to allow for controlled, sustained delivery of mesenchymal stem cell (MSC) secreted factors. This approach immobilizes the MSCs in an extracorporeal device, allowing for doses of therapeutic secreted factors that are unattainable by direct injection.
View Top Employees from Sentien Biotechnologies, Inc.| Website | http://www.sentienbiotech.com |
| Revenue | $13 million |
| Employees | 16 (4 on RocketReach) |
| Founded | 2008 |
| Address | 99 Hayden Ave Ste 140, Lexington, Massachusetts 02421, US |
| Phone | (781) 361-9031 |
| Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
| Industry | Biotechnology, Business Services General, Business Services, Science and Engineering, Health Care, Therapeutics |
| Web Rank | 12 Million |
| Keywords | Sentien Biotechnologies, Biotech Companies In Massachusetts, Bioworld Dea Class |
| Competitors | Athersys, DiscGenics, InGeneron, Longeveron Inc, Semma Therapeutics |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Sentien Biotechnologies, Inc. employee's phone or email?
Sentien Biotechnologies, Inc. Questions
The Sentien Biotechnologies, Inc. annual revenue was $13 million in 2024.
Brian Miller is the Chief Executive Officer, Co-Founder of Sentien Biotechnologies, Inc..
4 people are employed at Sentien Biotechnologies, Inc..
Sentien Biotechnologies, Inc. is based in Lexington, Massachusetts.
The NAICS codes for Sentien Biotechnologies, Inc. are [54171, 541, 541714, 54, 5417].
The SIC codes for Sentien Biotechnologies, Inc. are [87, 873].
Top Sentien Biotechnologies, Inc. Employees
-
25+
-
35+
Related Companies
